Ditchcarbon
  • Contact
  1. Organizations
  2. BioCell Technology
Public Profile
Health Services
DE
updated a month ago

BioCell Technology

Company websiteClaim

BioCell Technology, headquartered in Germany, is a leading innovator in the biotechnology industry, specialising in the development of advanced nutritional supplements and health products. Founded in 1997, the company has established a strong presence in major operational regions across Europe and North America, focusing on enhancing human health through scientifically-backed formulations. The core offerings of BioCell Technology include its flagship product, BioCell Collagen®, a patented ingredient renowned for its unique composition of hydrolysed collagen, chondroitin sulphate, and hyaluronic acid. This product stands out for its ability to support joint health, skin hydration, and overall wellness. With a commitment to quality and efficacy, BioCell Technology has garnered a notable market position, recognised for its contributions to the health and wellness sector.

DitchCarbon Score

How does BioCell Technology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

15

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

23

Industry Benchmark

BioCell Technology's score of 15 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.

13%

Let us know if this data was useful to you

BioCell Technology's reported carbon emissions

BioCell Technology, headquartered in Germany (DE), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that BioCell Technology may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). In the context of the industry, it is increasingly important for companies to adopt transparent climate strategies and set measurable targets to mitigate their environmental impact. Without specific emissions data or reduction commitments, BioCell Technology's climate strategy remains unclear, highlighting a potential area for future development in sustainability practices.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. BioCell Technology's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for BioCell Technology is in DE, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

BioCell Technology is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Thermo Fisher Scientific

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated about 15 hours ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 12 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251016.6
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy